Cantor Fitzgerald Reiterates “Overweight” Rating for BioMarin Pharmaceutical (NASDAQ:BMRN)
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report)‘s stock had its “overweight” rating reissued by investment analysts ...
US Commerce Secretary Howard Lutnick's Cantor Fitzgerald Increases Bitcoin Exposure Via ETFs, MSTR, MARA; Adds Chinese Firms Like BABA, Baidu, JD In Q4
US Commerce Secretary Howard Lutnick‘s hedge fund Cantor Fitzgerald LP increased the firm’s exposure to Bitcoin (CRYPTO: BTC) ...
US Senate Confirms Cantor Fitzgerald's Lutnick to Head Commerce Department
Senate Commerce Committee chair Ted Cruz said Lutnick will focus on issues including expanding commercial access to wireless ...
Cantor Fitzgerald Has Weak Forecast for PACB FY2025 Earnings
Analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for Pacific Biosciences of California in a note issued to investors on Tuesday, February 18th. Cantor Fitzgerald analyst R. Osborn now ...
Hosted on MSN2d
Cantor Fitzgerald Downgrades Supernus Pharmaceuticals (SUPN)
Fintel reports that on February 19, 2025, Cantor Fitzgerald downgraded their outlook for Supernus Pharmaceuticals ...
Five9 price target raised to $57 from $46 at Cantor Fitzgerald
Cantor Fitzgerald raised the firm’s price target on Five9 (FIVN) to $57 from $46 and keeps an Overweight rating on the shares. Give9 reported ...
‘We think the Mag7 are vulnerable’ - Cantor Fitzgerald
Cantor Fitzgerald came out and expressed concerns around the Magnificent Seven group, saying the stocks are “vulnerable.” ...
Brokers Offer Predictions for VRTX FY2025 Earnings
Cantor Fitzgerald issued their FY2025 EPS estimates for shares of Vertex Pharmaceuticals in a research note issued to ...
Cantor Fitzgerald Sticks to Their Hold Rating for Sabre (SABR)
Cantor Fitzgerald analyst Deepak Mathivanan reiterated a Hold rating on Sabre (SABR – Research Report) yesterday and set a price target of ...